Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report

Coronavirus disease 2019 (Covid-19) is associated with diffuse lung damage. Glucocorticoids may modulate inflammation-mediated lung injury and thereby reduce progression to respiratory failure and death.

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
Size: 922 KB